To bind or not to bind - FoxA1 determines estrogen receptor action in breast cancer progression

Chromatin immunoprecipitation followed by massively parallel sequencing (ChIP-seq) is rapidly enabling the comprehensive characterization of genome-wide transcription factor-binding sites, thus defining the cistrome (cis-acting DNA targets of a trans-acting factor). Estrogen receptor (ER) ChIP-seq s...

Descripción completa

Detalles Bibliográficos
Autores principales: Watters, Rebecca J, Benos, Panayiotis V, Oesterreich, Steffi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446328/
https://www.ncbi.nlm.nih.gov/pubmed/22713214
http://dx.doi.org/10.1186/bcr3146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446328/
https://www.ncbi.nlm.nih.gov/pubmed/22713214
http://dx.doi.org/10.1186/bcr3146

Ejemplares similares